Antimicrobial “Subscription” Plan Takes Hold in Britain

Decorative image of the AMR Learning Lounge

Antimicrobial “Subscription” Plan Takes Hold in Britain

SUMMARY

In April 2022, the UK’s National Health Service (NHS) officially agreed to pay a subscription-like fee over 10 years to drugmakers in exchange for two new drugs to treat antimicrobial resistant infections. Emily Spivak, MD discusses the potential for this approach in other nations while emphasizing the continued need for antimicrobial stewardship (AMS) practices.

FEATURED EXPERTS

Brian P. Dunleavy, MA, Association of Health Care Journalists

Emily Spivak, MD, Associate Professor at University of Utah School of Medicine; Chair of IDSA’ s Antimicrobial Resistance Committee

GET STARTED

Read the article at Contagion Live.

Take me there now!

Read time: 2 minutes

We want to hear from you!

Your feedback helps us continue to provide resources and content specific to your needs.

Take Our Poll

GLOBAL solutions

Optimize My Diagnostics for Antimicrobial Stewardship

Discover how to optimize your diagnostics for antimicrobial stewardship on our global website.

Learn More

US Solutions

Optimize My Diagnostics for Antimicrobial Stewardship

Healthcare professionals rely on accurate and timely diagnostic data to help guide patient treatment and fight AMR on the front lines. Learn how to optimize your diagnostics for antimicrobial stewardship on our website.

Learn More

PUBLISHED BY

Contagion Live - Infectious Diseases Today
April 21, 2022